Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 11 Hepatitis B 10 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Hepatitis B, Chronic 3 Stomach Neoplasms 1 Recurrence 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Arthritis, Rheumatoid 1

Interventions

Sorafenib 68 Bevacizumab 44 Oxaliplatin 25 Doxorubicin 22 Gemcitabine 21 Fluorouracil 21 Radiosurgery 20 Nivolumab 19 durvalumab 18 Radiofrequency Ablation 18 pembrolizumab 17 lenvatinib 17 Cisplatin 17 Capecitabine 17 atezolizumab 14 Leucovorin 14 Hepatectomy 14 Radiotherapy 12 tremelimumab 10 Irinotecan 10 Drug Therapy 10 Cyclophosphamide 10 Carboplatin 10 Blood Specimen Collection 10 Ipilimumab 9 regorafenib 8 Liver Transplantation 8 Everolimus 8 Cryosurgery 8 Chemotherapy, Adjuvant 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × entecavir × Clear all

NCT00555334 2009-04-01

LAM-RFA

Sun Yat-sen University

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡